216 results
Page 10 of 11
424B5
y55x7 bxqo
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
m1n 7jhhs1p0sznwv
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-99.1
ywkuq zklzh95ar
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
EX-99.1
imgs8e80trh fbg6l
8 Jan 15
ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board
12:00am
8-K
EX-99.1
a8ml 0thlf0
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
8-K
EX-99.1
4083jvb1
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
8-K
EX-99.1
k1ai4q
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am
8-K
EX-99.1
8qveg
11 Dec 14
Other Events
12:00am
8-K
EX-99.1
td558yff97hnabiqqgm0
9 Dec 14
Other Events
12:00am
8-K
8060p03
2 Dec 14
Submission of Matters to a Vote of Security Holders
12:00am
DEF 14A
tbs ohxty7
27 Oct 14
Definitive proxy
12:00am
PRER14A
s1yqs
23 Oct 14
Preliminary revised proxy
12:00am